T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Revolution Medicines
RVMD
$43.7B
| $141M | 0.02% |
5,094,706
+75,941
| +2% | +$2.25M |
|
452
Aptiv
APTV
$10.1B
| $141M | 0.02% |
1,426,753
-12,269
| -0.9% | -$1.27M |
|
453
Aurora
AUR
$13.5B
| $140M | 0.02% |
59,666,268
+59,445,241
| +26,895% | +$184M |
|
454
Tyler Technologies
TYL
$12.8B
| $139M | 0.02% |
360,255
+19,399
| +6% | +$7.62M |
|
455
Vornado Realty Trust
VNO
$7.42B
| $138M | 0.02% |
6,089,317
+200,135
| +3% | +$4.42M |
|
456
Weatherford International
WFRD
$6.69B
| $137M | 0.02% |
1,520,822
+601,257
| +65% | +$50.8M |
|
457
Main Street Capital
MAIN
$5.51B
| $137M | 0.02% |
3,363,810
-40,348
| -1% | -$1.65M |
|
458
AerCap
AER
$23.5B
| $136M | 0.02% |
2,167,206
-78,091
| -3% | -$4.92M |
|
459
Enbridge
ENB
$112B
| $135M | 0.02% |
4,079,250
+1,845,918
| +83% | +$65.5M |
|
460
Republic Services
RSG
$65.9B
| $133M | 0.02% |
936,610
-8,825
| -0.9% | -$1.31M |
|
|
VTYX
461
DELISTED
Ventyx Biosciences
VTYX
| $133M | 0.02% |
3,826,555
-122,738
| -3% | -$4.24M |
|
462
Neurocrine Biosciences
NBIX
$15.5B
| $133M | 0.02% |
1,179,650
-150,178
| -11% | -$15.8M |
|
463
Atmos Energy
ATO
$28.7B
| $132M | 0.02% |
1,247,209
-18,930
| -1% | -$2.21M |
|
464
Scholastic
SCHL
$781M
| $131M | 0.02% |
3,440,691
-634,475
| -16% | -$26.3M |
|
465
Immunocore
IMCR
$1.74B
| $131M | 0.02% |
2,521,284
+97,864
| +4% | +$5.79M |
|
|
SGEN
466
DELISTED
Seagen Inc. Common Stock
SGEN
| $130M | 0.02% |
612,737
-11,566
| -2% | -$2.31M |
|
467
Verra Mobility
VRRM
$709M
| $128M | 0.02% |
6,868,733
-521,635
| -7% | -$10.1M |
|
468
Norwegian Cruise Line
NCLH
$8.75B
| $128M | 0.02% |
7,743,757
+7,171,036
| +1,252% | +$132M |
|
469
Mettler-Toledo International
MTD
$28.6B
| $127M | 0.02% |
115,045
-2,966
| -3% | -$3.63M |
|
470
Lockheed Martin
LMT
$138B
| $127M | 0.02% |
311,331
+6,839
| +2% | +$3.03M |
|
471
Structure Therapeutics
GPCR
$3.83B
| $127M | 0.02% |
2,513,563
+740,213
| +42% | +$23.9M |
|
472
Arthur J. Gallagher & Co
AJG
$64.5B
| $126M | 0.02% |
554,207
+14,997
| +3% | +$3.36M |
|
473
RH
RH
$3.43B
| $126M | 0.02% |
475,296
+447,164
| +1,590% | +$155M |
|
474
Packaging Corp of America
PKG
$22.9B
| $125M | 0.02% |
815,387
-29,320
| -3% | -$4.28M |
|
475
Agilon Health
AGL
$1.48B
| $123M | 0.02% |
277,792
+122,124
| +78% | +$55.2M |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.